NCT00011414 2019-07-16Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed29 enrolled